(Q46196061)

20 December 2017

title

Osteopontin promoter polymorphisms at locus -443 significantly affect the metastasis and prognosis of human hepatocellular carcinoma (English)

1 reference

20 December 2017

author name string

Qiong-Zhu Dong

1

1 reference

20 December 2017

Xiao-Fei Zhang

2

1 reference

20 December 2017

Yue Zhao

3

1 reference

20 December 2017

Hu-Liang Jia

4

1 reference

20 December 2017

Hai-Jun Zhou

5

1 reference

20 December 2017

Chun Dai

6

1 reference

20 December 2017

Hai-Jing Sun

7

1 reference

20 December 2017

Yi Qin

8

1 reference

20 December 2017

Wei-De Zhang

9

1 reference

20 December 2017

Ning Ren

10

1 reference

20 December 2017

Qing-Hai Ye

11

1 reference

20 December 2017

Lun-Xiu Qin

12

1 reference

20 December 2017

language of work or name

English

0 references

publication date

11 February 2013

1 reference

20 December 2017

published in

Hepatology

1 reference

20 December 2017

volume

57

1 reference

20 December 2017

issue

3

1 reference

20 December 2017

page(s)

1024-1034

1 reference

20 December 2017

cites work

Global cancer statistics

1 reference

21 January 2018

Hepatocellular carcinoma

1 reference

Systemic endocrine instigation of indolent tumor growth requires osteopontin

21 January 2018

1 reference

Elevated plasma osteopontin associated with gastric cancer development, invasion and survival.

21 January 2018

1 reference

Increased expression of osteopontin contributes to the progression of prostate cancer

21 January 2018

1 reference

Elevated plasma osteopontin levels in patients with hepatocellular carcinoma.

21 January 2018

1 reference

Identification of osteopontin as a novel marker for early hepatocellular carcinoma

21 January 2018

1 reference

Down-regulation of osteopontin suppresses growth and metastasis of hepatocellular carcinoma via induction of apoptosis.

21 January 2018

1 reference

cDNA cloning, mRNA distribution and heterogeneity, chromosomal location, and RFLP analysis of human osteopontin (OPN)

21 January 2018

1 reference

Polymorphisms in the osteopontin promoter affect its transcriptional activity.

21 January 2018

1 reference

The impact of osteopontin promoter polymorphisms on the risk of calcium urolithiasis.

21 January 2018

1 reference

Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation

21 January 2018

1 reference

Haploview: analysis and visualization of LD and haplotype maps

21 January 2018

1 reference

Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning

21 January 2018

1 reference

Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma

21 January 2018

1 reference

Exploring the genomes of cancer cells: progress and promise

21 January 2018

1 reference

A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci

21 January 2018

1 reference

High-resolution characterization of a hepatocellular carcinoma genome

21 January 2018

1 reference

The regulation and role of osteopontin in malignant transformation and cancer

21 January 2018

1 reference

SNPs in the promoter region of the osteopontin gene as a marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C.

21 January 2018

1 reference

Genetic polymorphims in promoter region of osteopontin gene may be a marker reflecting hepatitis activity in chronic hepatitis C patients.

21 January 2018

1 reference

Cyclooxygenase‐2 gene promoter polymorphisms affect susceptibility to hepatitis C virus infection and disease progression

21 January 2018

1 reference

Single-nucleotide polymorphism in the promoter region of the osteopontin gene at nucleotide -443 as a marker predicting the efficacy of pegylated interferon/ribavirin-therapy in Egyptians patients with chronic hepatitis C.

21 January 2018

1 reference

Diagnosis and staging of hepatocellular carcinoma

21 January 2018

1 reference

Structure of the osteopontin gene and its promoter

21 January 2018

1 reference

The functional -443T/C osteopontin promoter polymorphism influences osteopontin gene expression in melanoma cells via binding of c-Myb transcription factor.

21 January 2018

1 reference

Beyond the transcripts: what controls protein variation?

21 January 2018

1 reference

The importance of phase information for human genomics

21 January 2018

1 reference

Thrombin is a therapeutic target for metastatic osteopontin-positive hepatocellular carcinoma

21 January 2018

1 reference

Serial Plasma Osteopontin Levels Have Prognostic Value in Metastatic Breast Cancer

21 January 2018

1 reference

7 January 2021

SPP1 promoter polymorphisms: identification of the first modifier gene for pseudoxanthoma elasticum

1 reference

7 January 2021

Two single-nucleotide polymorphisms in the 5' and 3' ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus

1 reference

7 January 2021

The implication of osteopontin (OPN) expression and genetic polymorphisms of OPN promoter in oral carcinogenesis

1 reference

7 January 2021

Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma

1 reference

7 January 2021

High-dose and long-term therapy with interferon-alfa inhibits tumor growth and recurrence in nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.26103

1 reference

20 December 2017

1 reference

20 December 2017